Neurologic Manifestations Clinical Trial
— KetCatOfficial title:
The Application of Ketamine for Sedation in Patients With Cardiac Arrest: Feasibility, Safety, and Potential Impact on Neurological Outcomes
Recent evidence suggests ketamine may attenuate harmful cellular cascades taking place after brain injury that result in permanent damage. The investigators are interested in researching the application of this in the setting of cardiac arrest. Following cardiac arrest, the brain is deprived oxygen for a period of time, leading to the imitation of these harmful cellular processes. The investigators hypothesize that patients who receive ketamine as part of their standard sedation procedures during cardiac arrest treatment have better neurological functioning compared to those who do not.
Status | Recruiting |
Enrollment | 24 |
Est. completion date | December 12, 2023 |
Est. primary completion date | December 9, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - All out-of-hospital cardiac arrests (OHCA) with a "shockable rhythm" (ventricular fibrillation, pulseless ventricular tachycardia) that present to the Royal Columbian Hospital. The patient may be either in active cardiac arrest with shockable rhythm or may have achieved Return of Spontaneous Circulation (ROSC). - Over 19 years of age - Patients requiring sedation based on the assessment of the resuscitating physician. Exclusion Criteria: - Any other type of cardiac arrest - Any history of previous, pre-existing neurological deficit - Started on Extracorporeal Membrane Oxygenation (ECMO) - Duration of cardiac arrest without ROSC is greater than 30 consecutive minutes - Known contraindication or hypersensitivity to ketamine - Awake patient or no standard sedation or no intubation required - Inability to obtain deferred consent - Currently enrolled in any other research study involving drugs or devices - Patients who are pregnant - Patients who are prisoners - Patients residing in Long Term Care (LTC) facilities |
Country | Name | City | State |
---|---|---|---|
Canada | Fraser Health Authority - Royal Columbian Hospital | New Westminster | British Columbia |
Lead Sponsor | Collaborator |
---|---|
Fraser Health |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility Data | To test the appropriateness of the eligibility criteria by recording enrolment rates of eligible patients, test the randomization assignment procedures by evaluating for any difference in baseline characteristics between groups, and test adequate adherence to protocol by recording time taken to administer intervention during sedation procedures. | through study completion, an average of 6 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04766645 -
ACE2 Gender Differences in Stroke With COVID-19
|
||
Completed |
NCT05086809 -
Investigation of an Updated Bone-anchored Sound Processor
|
N/A | |
Completed |
NCT00070681 -
Outcomes of Sleep Disorders in Older Men
|
Phase 3 | |
Terminated |
NCT00006321 -
Neurocognitive Function in Snoring Children
|
N/A | |
Terminated |
NCT03270189 -
Effect of the Visual Information Change in Functional Dystonia
|
N/A | |
Completed |
NCT04422925 -
s100β, NSE n GFAP in Living Donor Hepatectomy and Delirium
|
||
Suspended |
NCT04912115 -
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
|
Phase 2 | |
Completed |
NCT04568707 -
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)
|
N/A | |
Completed |
NCT02605733 -
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
|
||
Recruiting |
NCT01708668 -
The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia
|
N/A | |
Completed |
NCT00006424 -
Study of Brain Changes Shaped by Experience
|
N/A | |
Recruiting |
NCT03749538 -
Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
|
N/A | |
Not yet recruiting |
NCT06387290 -
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
|
N/A | |
Completed |
NCT02038491 -
RICALOR Italian Registry for Complications During Regional Anesthesia
|
N/A | |
Completed |
NCT04260035 -
The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients
|
N/A | |
Terminated |
NCT03913130 -
Extension Study to Study PQ-110-001 (NCT03140969)
|
Phase 1/Phase 2 | |
Completed |
NCT03471923 -
Non-Motor Features of Cervical Dystonia (CD)
|
||
Recruiting |
NCT04855045 -
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
|
Phase 2/Phase 3 | |
Completed |
NCT02418286 -
KLOS Study - Korean Medicine Registry for Low Back Pain Patients, a Prospective, Observational, Multicenter, Pilot Study
|
||
Completed |
NCT05523076 -
Transdiagnostic Markers of Cognitive Symptoms in Disorders Affective.
|